Stocks slump in August kick-off as data reignites slowdown worries
US manufacturing gauge drops to eight-month low
Arm Holdings down after tepid Q2 revenue forecast
Eli Lilly up as weight-loss drug cut heart failure risk in trial
Indexes down: Dow 1.21%, S&P 500 1.37%, Nasdaq 2.3%
Updated at 4:09 p.m. ET/2009 GMT
By Chuck Mikolajczak
NEW YORK, Aug 1 (Reuters) - U.S. stocks kicked off August sharply lower after a round of economic data on Thursday spurred concerns the economy may be slowing faster than anticipated while the Federal Reserve maintains a restrictive monetary policy.
Equities initially opened higher, buoyed in part by gains in Meta PlatformsMETA.O after its quarterly resultstopped expectations and the Facebook parent issued an upbeat outlook for the third quarter. Its shares closed 5.87% higher as the biggest boost to the S&P 500.
Early gains, however, evaporated after data showed a measure of manufacturing activity from the Institute for Supply Management (ISM) dropped to an eight-month low in July at 46.8, signifying contraction.
"It raises a genuine fear that the Fed is behind on cutting rates," Lou Basenese, president and chief market strategist at MDB Capital in New York.
"Few investors have confidence in the Fed sticking the proverbial soft landing and now the data is starting to support those concerns."
The Dow Jones Industrial Average .DJI fell 494.82 points, or 1.21%, to 40,347.97, the S&P 500 .SPX lost 75.62 points, or 1.37%, to 5,446.68 and the Nasdaq Composite .IXIC lost 405.25 points, or 2.30%, to 17,194.15.
August is typically one of the weakest months of the year for stocks.
Other data showed the number of Americans filing new applications for unemployment benefits increased to an 11-month high last week, suggesting some softening in the labor market, although seasonal factors also played a role.
Investors will eye the government payrolls report on Friday for any signs of further weakness in the labor market.
Both the S&P 500 and Nasdaq registered their biggest daily percentage gains since February in the prior session, boosted by a rally in chip shares after the Fed kept rates steady, as expected.
Defensive sectors such as utilities.SPLRCU and real estate.SPLRCR led gains, as geopolitical concerns over rising tensions in the Middle Eastboosted the dollar and pulled Treasuryyields lower.
Declines in megacap names such as AppleAAPL.O, down 1.68%, and AmazonAMZN.O, which lost 1.56% ahead of their quarterly results due after the closing bell weighed heavily on the tech .SPLRCT and consumer discretionary .SPLRCD indexes, which were among the worst performing of the 11 major S&P sectors.
After the closing bell, Amazon shares lost 4.47% following its quarterly results and outlook .
Of the 342 companies in the S&P 500 that have reported earnings through Thursday morning, 79.2% have topped analyst expectations, according to LSEG data, slightly above the 79% beat rate over the past four quarters. The estimated earnings growth rate for the quarter is 13.3%, up from 10.6% on July 1.
The small-cap Russell 2000 .RUT slumped 3.03% for its biggest daily percentage drop since Feb. 13. Small caps have been volatile recently as investors rotate between cheaper names and more expensive stocks.
"Without a good economy, these economically sensitive small stocks just won’t do anything, even with rate cuts," said Steve Sosnick, market strategist Interactive Brokers, Greenwich, Connecticut.
Nvidia NVDA.O dropped 6.67% in a broader chip stocks selloff sparked byArm Holdings' ARM.O conservative revenue forecast and Qualcomm QCOM.O flagging a revenue hit from the impact of trade curbs. ARM shares plummeted 15.72% while Qualcomm stumbled 9.37% as the PHLX semiconductor index .SOX lost 7.14% for its biggest daily percentage drop since March 2020.
Moderna MRNA.O plunged 21.01% after cutting its 2024 sales forecast for COVID-19 and respiratory syncytial virus vaccines by up to 25%.
Eli Lilly LLY.Nrose 3.5% aftertrial results showed weight-loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure.
Declining issues outnumbered advancers by a 2.04-to-1 ratio on the NYSE and on the Nasdaq, declining issues outnumbered advancers by a 3.19-to-1 ratio.
The S&P 500 posted 54 new 52-week highs and seven new lows while the Nasdaq Composite recorded 65 new highs and 177 new lows.
Volume on U.S. exchanges was 14.15 billion shares, compared with the 11.71 billion average for the full session over the last 20 trading days.
US unemployment claims https://reut.rs/3yqdYFJ
Q2 earnings growth on track for most S&P 500 sectors Q2 earnings growth on track for most S&P 500 sectors https://reut.rs/3Sv5ZOz
Reporting by Chuck Mikolajczak, additional reporting by Chibuike Oguh and Suzanne McGee; Editing by Marguerita Choy
Aset Berkaitan
Berita Terkini
Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.
Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.
Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.
